Local Woman First Patient to Receive Theralink Test
Imagine a magical, yet simple test in the cancer realm that maps out the exact treatment needed for care.That dream is becoming a reality, and the first patient in the world to receive such a test lives in Las Vegas.The test is calledTheralink, and the patient is Anicko Vallejo, a 29-yearold stage 1 breast cancer […]
Theralink® Technologies Appoints Thomas Chilcott as Chief Financial Officer
DENVER, Colorado — September 29, 2020 —Theralink Technologies (OTC: OBMP) (“Theralink” or the “Company”), a molecular profiling company specializing in patented, biomarker assay services that target multiple areas of oncology, today announced the appointment of Thomas E. Chilcott, III CPA as Chief Financial Officer, effective September 24, 2020. Mr. Chilcott joins Theralink Technologies with over […]
Theralink® Technologies Announces Corporate Name Change
DENVER, Colorado — September 24, 2020 —Theralink Technologies (OTC: OBMP) (“Theralink” or the “Company”), formerly OncBioMune Pharmaceuticals, Inc., a molecular profiling company specializing in patented, biomarker assay services that target multiple areas of oncology, today announced the completion of its previously announced corporate name change to Theralink Technologies, Inc., effective Thursday, September 24, 2020. “We […]
Theralink® Technologies Announces Strategic Translational Research Collaboration with BioMed Valley Discoveries
Golden, Colorado – September 15th, 2020 – Theralink Technologies, Inc., a molecular profiling company (OTC: OBMP), today announced a translational research collaboration with BioMed Valley Discoveries (BVD). Through this collaboration, Theralink Technologies will provide Laser Capture Microdissection (LCM) and Reverse Phase Protein Array (RPPA) services to assist BVD with translational research pertaining to first-in-class and […]